Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review)
The review focuses on the main aspects of the use of antithrombotic agents in women during pregnancy and lactation. It summarises the reasons for frequent development of gestational hypercoagulable state, which provokes some obstetric complications (preeclampsia, etc.) and increases the possibility...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-04-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2367 |
| _version_ | 1797841638642417664 |
|---|---|
| author | A. E. Bagry O. A. Prikolota E. V. Schukina M. V. Khomenko E. E. Kovyrshina |
| author_facet | A. E. Bagry O. A. Prikolota E. V. Schukina M. V. Khomenko E. E. Kovyrshina |
| author_sort | A. E. Bagry |
| collection | DOAJ |
| description | The review focuses on the main aspects of the use of antithrombotic agents in women during pregnancy and lactation. It summarises the reasons for frequent development of gestational hypercoagulable state, which provokes some obstetric complications (preeclampsia, etc.) and increases the possibility of the occurrence of serious clinical situations such as lower extremity deep vein thrombosis and pulmonary embolism, thrombotic/thromboembolic complications in thrombophilia and antiphospholipid syndrome of various genesis, as well as prosthetic heart valves. It provides a brief description of antithrombotic agent groups and advanced approaches to the selection of antithrombotic agents in pregnant and lactating women. This article discusses in details individual clinical situations during which the agents under discussion may be used during pregnancy and lactation (prevention of preeclampsia, treatment of thrombotic and thromboembolic complications, prophylaxis of the latter, if patients are required to be on bed rest for more than 24 hours, planning for caesarean section and epidural anaesthesia, and in thrombophilia, antiphospholipid syndrome, prosthetic heart valves) according to the current Guidelines. |
| first_indexed | 2024-04-09T16:34:37Z |
| format | Article |
| id | doaj.art-847ceb0684324e4981b6ea5158c5e38b |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:34:37Z |
| publishDate | 2018-04-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-847ceb0684324e4981b6ea5158c5e38b2023-04-23T06:56:57ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-04-0106192510.21518/2079-701X-2018-6-19-252343Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review)A. E. Bagry0O. A. Prikolota1E. V. Schukina2M. V. Khomenko3E. E. Kovyrshina4Gorky Donetsk National Medical University of the Ministry of HealthGorky Donetsk National Medical University of the Ministry of HealthGorky Donetsk National Medical University of the Ministry of HealthGorky Donetsk National Medical University of the Ministry of HealthDonetsk Regional In-Patient Medical Association of the Ministry of HealthThe review focuses on the main aspects of the use of antithrombotic agents in women during pregnancy and lactation. It summarises the reasons for frequent development of gestational hypercoagulable state, which provokes some obstetric complications (preeclampsia, etc.) and increases the possibility of the occurrence of serious clinical situations such as lower extremity deep vein thrombosis and pulmonary embolism, thrombotic/thromboembolic complications in thrombophilia and antiphospholipid syndrome of various genesis, as well as prosthetic heart valves. It provides a brief description of antithrombotic agent groups and advanced approaches to the selection of antithrombotic agents in pregnant and lactating women. This article discusses in details individual clinical situations during which the agents under discussion may be used during pregnancy and lactation (prevention of preeclampsia, treatment of thrombotic and thromboembolic complications, prophylaxis of the latter, if patients are required to be on bed rest for more than 24 hours, planning for caesarean section and epidural anaesthesia, and in thrombophilia, antiphospholipid syndrome, prosthetic heart valves) according to the current Guidelines.https://www.med-sovet.pro/jour/article/view/2367antithrombotic agentspregnancylactation |
| spellingShingle | A. E. Bagry O. A. Prikolota E. V. Schukina M. V. Khomenko E. E. Kovyrshina Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) Медицинский совет antithrombotic agents pregnancy lactation |
| title | Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
| title_full | Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
| title_fullStr | Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
| title_full_unstemmed | Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
| title_short | Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
| title_sort | use of antithrobomic agents in pregnancy and lactation from the viewpoint of the cardiologist rheumatologist literature review |
| topic | antithrombotic agents pregnancy lactation |
| url | https://www.med-sovet.pro/jour/article/view/2367 |
| work_keys_str_mv | AT aebagry useofantithrobomicagentsinpregnancyandlactationfromtheviewpointofthecardiologistrheumatologistliteraturereview AT oaprikolota useofantithrobomicagentsinpregnancyandlactationfromtheviewpointofthecardiologistrheumatologistliteraturereview AT evschukina useofantithrobomicagentsinpregnancyandlactationfromtheviewpointofthecardiologistrheumatologistliteraturereview AT mvkhomenko useofantithrobomicagentsinpregnancyandlactationfromtheviewpointofthecardiologistrheumatologistliteraturereview AT eekovyrshina useofantithrobomicagentsinpregnancyandlactationfromtheviewpointofthecardiologistrheumatologistliteraturereview |